Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma:a second look

Avrum Z. Bluming, Charles L. Vogel, John L. Ziegler, Jovan W.M. Kiryabwire

Research output: Contribution to journalArticlepeer-review

38 Scopus citations


Sixteen consecutively admitted patients with malignant melanoma were skin tested with autologous lumor extract (ATE), a varietyof cutaneous antigens, and when available, autologous normal skin extracts (ASE). A protein concentralion of 1 mg/ml was used as the criticalantigenic challenge for both ATE and ASE testing. Anergy was not encountered in any of this group. Positive delayed sensitivity reactions toATE were elicited in 11 patients, 9 of whom were also tested with ASE.Six of the nine (67%) reacted to the ASE as well. The implications of concomitant ATE and ASE reactivity are discussed. No correlation was notedbetween ASE reactivity and the presence of vitiligo in these patients. Nocorrelation was noted between ATE skin-test reactivity and sex, age, length of history prior to hospitalization, primary disease site, presence ofregional node involvement, distant metastases, vitiligo, or duration ofremission, even in the 3 patients reacting to ATE and not to ASE. Naturallyoccurring cutaneous reactivity to extracts of autologous melanoma cellsdoes not currently appear to represent an effective immunological barrierto tumor progression, though future studies may suggest significant clinicalapplication of this phenomenon.—J Nat Cancer Inst 48: 17-24, 1972.

Original languageEnglish (US)
Pages (from-to)17-24
Number of pages8
JournalJournal of the National Cancer Institute
Issue number1
StatePublished - Jan 1972
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma:a second look'. Together they form a unique fingerprint.

Cite this